Saquayamycin C
Saquayamycin C has antimicrobial effect, but it has weaker effect against Gram-negative bacteria. Saquayamycin C has inhibitory effect on leukemia P388 cells and Adriamycin-resistant P388 cells[1].
Product Specifications
CAS Number
[99260-70-5]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Smiles
O=C1C(C=C[C@]2(O)C[C@](O[C@H]3CC[C@@H]([C@@H](O3)C)O[C@H]4CCC([C@@H](O4)C)=O)(C)CC5=O)=C([C@]25O)C(C6=CC=C(C(O)=C16)[C@@H]7O[C@@H]([C@H]([C@@H](C7)O)O[C@@H]8O[C@H](C(CC8)=O)C)C)=O
Molecular Formula
C43H52O16
Molecular Weight
824.86
References & Citations
[1]T Uchida, et al. Saquayamycins, new aquayamycin-group antibiotics. J Antibiot (Tokyo) . 1985 Sep;38 (9) :1171-81.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6158033-01 0.1 mL
GNGT1 (Guanine Nucleotide-binding Protein G(T) Subunit gamma-T1, Transducin gamma Chain) (PE)
Ask
View Details 
MBS6158033-02 5x 0.1 mL
GNGT1 (Guanine Nucleotide-binding Protein G(T) Subunit gamma-T1, Transducin gamma Chain) (PE)
Ask
View Details 
MBS1307109-01 0.02 mg (E-Coli)
Recombinant Human Putative uncharacterized protein C16orf47 (C16orf47)
Ask
View Details MBS1307109-02 0.1 mg (E-Coli)
Recombinant Human Putative uncharacterized protein C16orf47 (C16orf47)
Ask
View Details MBS1307109-03 0.02 mg (Yeast)
Recombinant Human Putative uncharacterized protein C16orf47 (C16orf47)
Ask
View Details MBS1307109-04 0.1 mg (Yeast)
Recombinant Human Putative uncharacterized protein C16orf47 (C16orf47)
Ask
View Details